Medical diagnostic companies have seen significant growth, especially during the COVID-19 pandemic. The sector is now marked by major innovations, with the advent of new molecular and genetic diagnostic technologies that enable faster and more accurate diagnostics, facilitating patient care.
Thanks to artificial intelligence, mobile applications are transforming smartphones into pre-diagnostic tools, raising challenges related to integration into healthcare pathways and financing. The sector faces several constraints, including inflation, funding difficulties, and the ability to meet the growing demand for rapid and precise diagnostics.
Our Support
We support pharmaceutical industry players in tackling these challenges with our expertise in:
Market Access
Defining and implementing patient access strategies, preparing early access and evaluation dossiers, supporting pricing negotiations for healthcare products, and developing Stakeholder Engagement Plans, etc.
Public Affairs
Structuring strategic roadmaps and advocacy, forming coalitions, deploying awareness campaigns involving public and private stakeholders, lobbying, organizing events bringing together public decision-makers and stakeholders, establishing observatories, etc.
Strategy and Transformation
Defining strategic roadmaps, supporting organizational transformation, analyzing and assisting in the strengthening of patient pathways, supporting the development of solutions and services that create value for patients, assisting in digital transformation, engaging in CSR initiatives, seeking funding, etc.
Training, Information, and Publications
Analyzing current issues, publishing reports, conducting deep-dives for teams, training your partners (patients, healthcare professionals, leadership coaching and board committees on key healthcare system issues), strategic monitoring, preparing informational reports, etc.
Related posts
Would you like to speak with our experts?
